北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (6): 1178-1184. doi: 10.19723/j.issn.1671-167X.2022.06.020

• 论著 • 上一篇    下一篇

内镜下逆行胰胆管造影在胆肠吻合术后患者中的应用

郑炜,黄永辉*(),常虹,姚炜,李柯,闫秀娥,张耀朋,王迎春,刘文正   

  1. 北京大学第三医院消化科,北京 100191
  • 收稿日期:2022-04-13 出版日期:2022-12-18 发布日期:2022-12-19
  • 通讯作者: 黄永辉 E-mail:13911765322@163.com
  • 基金资助:
    国家自然科学基金(82070653);首都临床特色应用研究(z171100001017091)

Endoscopic retrograde cholangiopancreatography in patients after bilioenteric anstomosis

Wei ZHENG,Yong-hui HUANG*(),Hong CHANG,Wei YAO,Ke LI,Xiu-e YAN,Yao-peng ZHANG,Ying-chun WANG,Wen-zheng LIU   

  1. Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China
  • Received:2022-04-13 Online:2022-12-18 Published:2022-12-19
  • Contact: Yong-hui HUANG E-mail:13911765322@163.com
  • Supported by:
    the National Natural Science Foundation of China(82070653);the Capital Foundation for Clinical Characteristics and Application Research(z171100001017091)

摘要:

目的: 通过回顾北京大学第三医院近年来不同胆肠吻合术后行内镜逆行胰胆管造影术(endoscopic retrograde cholangiopancreatography,ERCP)患者的临床资料并再次阅读内镜图片,分析不同类型胆肠吻合术后特别是胃肠改道术后ERCP的特点、安全性和有效性。方法: 收集2005年1月至2021年12月在北京大学第三医院内镜中心因胆系疾病接受ERCP的胆肠吻合术后患者的临床资料及内镜图片,分为胆管-十二指肠吻合术(choledochoduodenostomy,CDD)、Roux-en-Y胆肠吻合术(Roux-en-Y hepaticojejunostomy,RYHJ)和Whipple术后三组,以及ERCP成功和失败两组,进行组间比较统计分析。结果: 共纳入89例患者,ERCP操作132例次,患者年龄9~80岁,中位年龄57岁,包括CDD组4例,RYHJ组30例,Whipple组54例,胆管-回盲部吻合1例。ERCP距手术的时间分别为30 (1~40)、2.75 (0.5~14)、2 (0.3~19)和10年,手术后出现胆系疾病症状的时间分别为240 (3~360)、12 (1~156)、22 (0~216)和60个月。50%的CDD经局部麻醉操作即可成功,RYHJ(96.7%)和Whipple(100%)基本均为全身麻醉,组间差异有统计学意义(P < 0.001)。CDD组首次进镜成功率为100.0%,RYHJ组和Whipple组分别为40.0%和77.8%,更换内镜后分别提升至43.3%和83.3%,不同术式间进镜成功率的比较差异有统计学意义(P < 0.001)。CDD、RYHJ、Whipple组插管成功率分别为100.0%、53.8%、86.7%,组间差异有统计学意义(P=0.031)。CDD、RYHJ、Whipple组ERCP成功率分别为100.0%、33.3%、78.8%,组间差异有统计学意义(P < 0.001)。术后并发症发生率为23.9%(21/88),分别为感染(14.8%)、胰腺炎(9.2%)、出血(3.4%)、穿孔(2.3%)。胆肠吻合术后ERCP的常见原因分别为吻合口狭窄(50.0%,良性狭窄39.3%,恶性狭窄10.7%)、胆管结石(37.5%)、反流性胆管炎(12.5%)。吻合方式为预判ERCP成功与否的唯一因素(OR=7, 95%CI:2.591~18.912,P < 0.001)。结论: 伴胃肠改道的胆肠吻合术后ERCP需在全身麻醉下进行,具有良好的安全性和有效性,RYHJ的成功率显著低于Whipple术后,手术方式是决定ERCP能否成功的唯一影响因素。

关键词: 内镜逆行胰胆管造影术, 胆肠吻合, Roux-en-Y吻合术, 胃肠道内镜检查

Abstract:

Objective: To distinguish clinical features, safety and efficiency of endoscopic retrograde cholangiopancreatography (ERCP) in patients after bilioenteric anstomosis based on retrospectively analyzed clinical data and endoscopy procedures. Methods: Data extracted from patients after bilioenteric anstomosis due to biliary disease treated with ERCP from January 2005 to December 2021 in the Department of Gastroenterology, Peking University Third Hospital were retrospectively analyzed. Clinical data and endoscopic pictures were reevaluated and analyzed. The patients were divided into three groups, including the patients with choledochoduodenostomy (CDD), Roux-en-Y hepaticojejunostomy (RYHJ) and Whipple. Differences between ERCP success and failure were conducted. Results: In the study, 89 cases with 132 ERCP procedures were involved, 9-80 years old, median 57 years old, containing 4 CDD, 30 RYHJ, 54 Whipple and 1 bile duct ileocecal anastomosis patients; The time between ERCP and surgery were 30 (1-40), 2.75 (0.5-14), 2 (0.3-19), and 10 years, respectively; The time between surgery and symptom were 240 (3-360), 12 (1-156), 22 (0-216), and 60 months, respectively. Fifty percent of CDD could succeed only under local anaesthesia, RYHJ (96.7%) and Whipple (100.0%) needed under general anaesthesia (P < 0.001). Successful first entry rates of CDD, RYHJ and Whipple were 100.0%, 40.0% and 77.8%, respectively. After changing the endoscopy type, successful entry rate could increase to 43.3% of RYHJ and 83.3% of Whipple. The successful entry rate of different anastomotic methods was significant (P < 0.001). The cannulation success rates of CDD, RYHJ and Whipple were 100.0%, 53.8% and 86.7% respectively, with significant difference between the groups (P=0.031). ERCP success rates of CDD, RYHJ and Whipple were 100.0%, 33.3% and 78.8% respectively, with significant difference between the groups (P < 0.001). Complications were found in 23.9% (21/88) patients, including infection (14.8%), pancreatitis (9.2%), bleeding (3.4%), and perforation (2.3%) ranked by incidence. Causes of ERCP in post bilioenteric anstomosis were anastomotic stenosis (50.0%, benign 39.3%, malignant 10.7%), choledocholithiasis (37.5%) and reflux cholangitis (12.5%). Anastomotic method was the only predicting factor of ERCP success in patients after bilioenteric anstomosis (OR=7, 95%CI: 2.591-18.912, P < 0.001). Conclusion: ERCP in post bilioenteric anstomosis patients with gastrointestinal reconstruction need general anaesthe-sia, with good safety and efficiency. The successful rate of RYHJ was significantly lower than Whipple. Anastomotic method was the only predicting factor of ERCP success.

Key words: Endoscopic retrograde cholangiopancreatography, Bilioenteric anastomosis, Roux-en-Y anastomosis, Gastrointestinal endoscopy

中图分类号: 

  • R657.4

表1

不同术式患者的一般情况"

Anastomotic method Time between ERCP and surgery/years, M (range) Time between surgery and symptom/months, M (range) Male, n (%)
CDD (n=4) 30 (1-40) 240 (3-360) 1 (25.0)
RYHJ (n=30) 2.75 (0.5-14) 12 (1-156) 14 (46.7)
Whipple (n=54) 2 (0.3-19) 22 (0-216) 30 (55.6)
Bile duct ileocecal anastomosis (n=1) 10 60 0 (0)
Total (n=89) 2.75 (0.3-40) 21 (0-360) 45 (50.6)
P value 0.104 0.205 0.577

表2

不同术式的临床特征"

Variable Total (n=88) CDD (n=4) RYHJ (n=30) Whipple (n=54) P value
Age/years 55.9±12.9 53.8±15.7 52.4±13.0 58.1±12.4 0.137
Cause of surgery
   Benign 27 (30.7) 3 (75.0) 23 (76.7) 1 (1.9) < 0.001
   Malignant 61 (69.3) 1 (25.0) 7 (23.3) 53 (98.1)
History
   Duration/months 5.5 (0.1-132.0) 38.5 (0.1-120.0) 6.0 (0.1-132.0) 4.0 (0.3-50.0) 0.237
   Cholangitis 69 (78.4) 3 (75.0) 25 (83.3) 41 (75.9) 0.728
   Alcohol 25 (28.4) 0 (0) 10 (33.3) 15 (27.8) 0.385
   Hypertension 15 (17.0) 0 (0) 5 (16.7) 10 (18.5) 0.644
   Diabetes 24 (27.3) 0 (0) 7 (23.3) 17 (31.5) 0.338
   Hospitalization/d 9.0 (3.0-60.0) 8.5 (5.0-11.0) 10.0 (5.0-28.0) 8.0 (3.0-60.0) 0.514
ERCP procedure
   Anesthesia 85 (96.6) 2 (50.0) 29 (96.7) 54 (100.0) < 0.001
   Successful 1st entry 58 (65.9) 4 (100.0) 12 (40.0) 42 (77.8) < 0.001
   Successful 2nd entry 11 (12.5) - 6 (20.0) 5 (9.3) 0.363
   Successful entry 62 (70.5) 4 (100.0) 13 (43.3) 45 (83.3) < 0.001
Endoscopy used in cannulation 0.359
   GE 3 (4.8) 0 (0) 0 (0) 3 (6.7)
   DE 4 (6.5) 3 (75.0) 1 (7.7) 0 (0)
   CE 49 (79.0) 0 (0) 8 (61.5) 41 (91.1)
   SBE/DBE 4 (6.5) 0 (0) 4 (30.8) 0 (0)
   DCE/PTC 2 (3.2) 1 (25.0) 0 (0) 1 (2.2)
Cannulating technique 0.031
   Standard 50 (80.6) 4 (100.0) 7 (53.8) 39 (86.7)
   Change endoscope 11 (17.7) 0 (0) 6 (46.2) 5 (11.1)
   PTC assistant 1 (1.6) 0 (0) 0 (0) 1 (2.2)
   Successful cannulate 57 (91.9) 4 (100.0) 11 (84.6) 42 (93.3) 0.508
   Successful ERCP 56 (63.6) 4 (100.0) 10 (33.3) 42 (77.8) < 0.001
Complications
   AP 8 (9.2) 0 (0) 4 (13.3) 4 (7.4) < 0.001
   Infection 13 (14.8) 1 (25.0) 4 (13.3) 8 (14.8) 0.845
   Bleeding 3 (3.4) 0 (0) 0 (0) 3 (5.6) 0.396
   Perforation 2 (2.3) 0 (0) 0 (0) 2 (3.7) 0.544
CT consistency 58 (65.9) 2 (50.0) 22 (73.3) 34 (63.0) 0.004
MRCP consistency 63 (71.6) 3 (75.0) 22 (73.3) 38 (70.4) 0.062

表3

胆肠吻合术后ERCP的病因"

Indications Total (n=56) CDD (n=4) RYHJ (n=10) Whipple (n=42)
Choledocholithiasis 21 (37.5) 1 (25.0) 3 (30.0) 17 (40.5)
Anastomotic stenosis 28 (50.0) 1 (25.0) 7 (50.0) 22 (52.4)
   Benign 22 (39.3) 1 (25.0) 4 (40.0) 17 (40.5)
   Malignant 6 (10.7) 0 (0) 1 (10.0) 5 (11.9)
Reflux cholangitis 7 (12.5) 2 (50.0) 2 (20.0) 3 (7.1)

表4

ERCP成功和失败患者的临床特点"

Variable Succeed Failure t/Z value P value
Age/years 56.8±13.3 54.4±13.2 0.856 0.394
Male 31 (55.4) 14 (43.8) 0.295
Cause of surgery 0.013
   Benign 12 (21.4) 15 (46.9)
   Malignant 44 (78.6) 17 (53.1)
History
   Duration/month 2 (0-120) 6 (0.5-132) 1.797 0.072
   Time between ERCP and surgery/years 4.0 (0.5-40.0) 3.0 (0.3-19.0) 0.135 0.892
   Time between surgery and symptom/month 12 (0-360) 20.5 (1-216) 0.864 0.387
   Cholangitis 46 (82.1) 23 (71.9) 0.260
   Alcohol 14 (25.0) 11 (34.4) 0.348
   Hypertension 8 (14.3) 7 (21.9) 0.362
   Diabetes 16 (28.6) 8 (25.0) 0.717
   Hospitalization/d 8 (3-44) 10 (3-60) 1.578 0.114
   Anesthesia 54 (96.4) 31 (96.9) 0.911
1 Dimou FM , Adhikari D , Mehta HB , et al. Incidence of hepaticojejunostomy stricture after hepaticojejunostomy[J]. Surgery, 2016, 160 (3): 691- 698.
doi: 10.1016/j.surg.2016.05.021
2 Takano S , Fukasawa M , Shindo H , et al. Risk factors for perforation during endoscopic retrograde cholangiopancreatography in post-reconstruction intestinal tract[J]. World J Clin Cases, 2019, 7 (1): 10- 18.
doi: 10.12998/wjcc.v7.i1.10
3 Kawaguchi Y , Yamauchi H , Kida M , et al. Failure factors to reach the blind end using a short-type single-balloon enteroscope for ERCP with Roux-en-Y reconstruction: A multicenter retrospective study[J]. Gastroenterol Res Pract, 2019, 2019, 3536487.
4 Barakat MT , Adler DG . EUS-directed transgastric ERCP: A first-line option for ERCP following Roux-en-Y gastric bypass[J]. Endosc Ultrasound, 2021, 10 (3): 151- 153.
doi: 10.4103/eus.eus_148_20
5 Itokawa F , Itoi T , Ishii K , et al. Single- and double-balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y plus hepaticojejunostomy anastomosis and Whipple resection[J]. Dig Endosc, 2014, 26 (Suppl 2): 136- 143.
6 Gómez V , Petersen BT . Endoscopic retrograde cholangiopan-creatography in surgically altered anatomy[J]. Gastrointest Endosc Clin N Am, 2015, 25 (4): 631- 656.
doi: 10.1016/j.giec.2015.06.001
7 Escudero-Fabre A , Escallon A , Jr. Sack J , et al. Choledochoduodenostomy. Analysis of 71 cases followed for 5 to 15 years[J]. Ann Surg, 1991, 213 (6): 635- 644.
doi: 10.1097/00000658-199106000-00014
8 Uwuratuw JA , Bakhtiar B , Labeda I , et al. Recurrent cholangitis after choledochoduodenostomy: A case report[J]. Int J Surg Case Rep, 2022, 92, 106912.
doi: 10.1016/j.ijscr.2022.106912
9 Nennstiel S , Freivogel K , Faber A , et al. Endoscopic and percutaneous biliary interventions in patients with altered upper gastrointestinal anatomy: The Munich Multicenter Experience[J]. Surg Endosc, 2021, 35 (12): 6853- 6864.
doi: 10.1007/s00464-020-08191-2
10 Tanisaka Y , Ryozawa S , Mizuide M , et al. Status of single-balloon enteroscopy-assisted endoscopic retrograde cholangiopan-creatography in patients with surgically altered anatomy: Systematic review and meta-analysis on biliary interventions[J]. Dig Endosc, 2021, 33 (7): 1034- 1044.
doi: 10.1111/den.13878
11 Wang F , Xu B , Li Q , et al. Endoscopic retrograde cholangiopancreatography in patients with surgically altered anatomy: One single center's experience[J]. Medicine (Baltimore), 2016, 95 (52): e5743.
doi: 10.1097/MD.0000000000005743
12 Enestvedt BK , Kothari S , Pannala R , et al. Devices and techniques for ERCP in the surgically altered GI tract[J]. Gastro-intest Endosc, 2016, 83 (6): 1061- 1075.
doi: 10.1016/j.gie.2016.03.018
13 Cho E , Park CH , Kim Y , et al. Impact of scope exchange from a long single balloon enteroscope to a gastroscope during enteroscopy-assisted endoscopic retrograde cholangiopancreatography in patients with surgically altered anatomy[J]. Gut Liver, 2022, 16 (2): 308- 316.
doi: 10.5009/gnl210088
14 Hammad H , Brauer BC , Smolkin M , et al. Treating biliary-enteric anastomotic strictures with enteroscopy-ERCP requires fewer procedures than percutaneous transhepatic biliary drains[J]. Dig Dis Sci, 2019, 64 (9): 2638- 2644.
doi: 10.1007/s10620-019-05670-y
15 Weilert F , Binmoeller KF , Marson F , et al. Endoscopic ultrasound-guided anterograde treatment of biliary stones following gastric bypass[J]. Endoscopy, 2011, 43 (12): 1105- 1108.
doi: 10.1055/s-0030-1256961
[1] 张铃福,侯纯升,徐智,王立新,凌晓锋,王港,崔龙,修典荣. 腹腔镜下经胆囊管胆管引流联合胆总管探查取石术治疗复杂胆管结石的临床效果[J]. 北京大学学报(医学版), 2022, 54(6): 1185-1189.
[2] 张铃福,侯纯升,黄永辉,徐智,王立新,凌晓锋,王港,崔龙,修典荣. 胃空肠吻合术后胆总管结石腹腔镜手术取石和内镜取石的比较[J]. 北京大学学报(医学版), 2019, 51(2): 345-348.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[2] 管宏, 赵慧云, 沈磊, 李五岭, 王建华, 王春荣, 徐福. 联合应用重组TPO和G-CSF对骨髓抑制性小鼠外周血小板及白细胞恢复的影响[J]. 北京大学学报(医学版), 2001, 33(2): 181 -182 .
[3] 牟向东, 王广发, 阙呈立, 李桂莲. H3N2型人流行性感冒合并金黄色葡萄球菌败血症及金黄色葡萄球菌肺炎1例[J]. 北京大学学报(医学版), 2007, 39(6): 663 -665 .
[4] 范蓉, 张成飞, 高岩, 李斌斌, 王晶. 核因子-κB受体活化因子配体和骨保护素在慢性根尖周炎病损组织中的表达[J]. 北京大学学报(医学版), 2008, 40(1): 39 -42 .
[5] 徐京杭, 于岩岩, 斯崇文, 陈新月, 韩忠厚, 陈勇, 张文谨, 徐道振, 陈宇萍, 于敏, 席宏丽, 李雪迎. 拉米夫定或干扰素单药治疗及序贯治疗慢性乙型肝炎的随机对照临床研究[J]. 北京大学学报(医学版), 2010, 42(6): 739 -745 .
[6] 钟金晟, 欧阳翔英, 梅芳, 邓旭亮, 曹采方. 多孔β-磷酸三钙/胶原支架与犬牙周膜细胞三维复合体的构建[J]. 北京大学学报(医学版), 2007, 39(5): 507 -510 .
[7] 范少光. 向王志均院士学习[J]. 北京大学学报(医学版), 2000, 32(4): 300 .
[8] 李智岗, 黄景香, 李顺宗, 赵俊京, 时高峰, 梁国庆, 王红光, 韩捧银, 王琦, 谷铁树. 肝转移瘤的血供[J]. 北京大学学报(医学版), 2008, 40(2): 146 -150 .
[9] 冯现竹, 侯平, 朱厉, 于磊, 张宏. 转铁蛋白受体基因多态性与IgA肾病易感性及临床病理表型的相关性[J]. 北京大学学报(医学版), 2008, 40(4): 369 -373 .
[10] 王倩, 张翼, 陆敏, 管又飞, 朱毅, 王悦. 高盐诱导的高血压大鼠模型肾组织可溶性表氧化物酶高表达及其作用初步探讨[J]. 北京大学学报(医学版), 2010, 42(2): 126 -130 .